logo

CRDF

Cardiff Oncology·NASDAQ
--
--(--)
--
--(--)

CRDF fundamentals

Cardiff Oncology (CRDF) released its earnings on Nov 6, 2025: revenue was 120.00K (YoY -27.27%), missed estimates; EPS was -0.17 (YoY +32.00%), beat estimates.
Revenue / YoY
120.00K
-27.27%
EPS / YoY
-0.17
+32.00%
Report date
Nov 6, 2025

Earnings

EPS
Revenue

Revenue & Expenses

CRDF has released its 2025 Q4 earnings report, with revenue of 243.00K, reflecting a YoY change of 60.93%, and net profit of -7.22M, showing a YoY change of 38.78%. The Sankey diagram below clearly presents CRDF's revenue sources and cost distribution.

Key Indicators

Cardiff Oncology (CRDF) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cardiff Oncology (CRDF)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Cardiff Oncology (CRDF)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Cardiff Oncology (CRDF)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Cardiff Oncology (CRDF) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Cardiff Oncology (CRDF) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield